4G Clinical Stock
We are equipped to answer the extreme cost and time pressures of clinical trials unlike anyone else.
Sign up today and learn more about 4G Clinical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About 4G Clinical Stock
We reduce the time it takes to commercialize vital medications by delivering validated, easily extended RTSM capabilities faster than anyone in the world.
Funding History
| January 2016 | $2.5M |
|---|---|
| October 2016 | $5.0M |
Management
COO
Christine Hurley
Co-Founder & CTO
Ed Tourtellotte
Co-Founder & CEO
David Kelleher
Head of Engineering
Cedric Druck
Press
patents - Apr, 14 2024
Systems and methods for demand and supply forecasting for clinical trialspatents - Apr, 14 2024
Generating RTSM Systems for Clinical Trialspatents - Apr, 14 2024
Automated randomization validation for an rtsm systempatents - Apr, 14 2024
Automated randomization validation for an rtsm systemEquityZen Recognized As:
